BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

11394

0

ZOTA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ZOTA HEALTH CARE LIMITED performance

Today’s low

Today’s high

₹ 1105.00 ₹ 1210.25
₹ 1199.80

52 week low

52 week high

₹ 535.00 ₹ 1210.25
₹ 1199.80

Open Price

₹ 1146.95

Prev. Close

₹ 1146.95

Volume (Shares)

398005.00

Total traded value

₹ 4775.26

Upper Circuit

₹ 1376.30

Lower Circuit

₹ 917.60

info

ZOTA HEALTH CARE LIMITED Share Price Update

As of the latest trading session, ZOTA HEALTH CARE LIMITED share price is currently at ₹ 1199.8, which is up by ₹ 52.85 from its previous closing. Today, the stock has fluctuated between ₹ 1105.00 and ₹ 1210.25. Over the past year, ZOTA HEALTH CARE LIMITED has achieved a return of 98.54 %. In the last month alone, the return has been 24.38 %. Read More...

Investment Returns

Over 1 Month 24.38% Over 3 Months 47.11% Over 6 Months 40.54% Over 1 Year 98.54%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ZOTA HEALTH CARE LIMITED fundamentals


  • Market cap (Cr)

    3,531.00

  • P/E Ratio (TTM)

    409.49

  • Beta

    1.09

  • Book Value / share

    132.14

  • Return on equity

    3.13%

  • EPS (TTM)

    2.93

  • Dividend yield

    0.08%

  • Net profit/quarter (Cr)

    2.60

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.08%

  • Net profit/quarter (Cr)

info icon alternate text

ZOTA HEALTH CARE LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 77.93
Operating Expense 75.01
Net Profit 2.60
Net Profit Margin (%) 3.33
Earnings Per Share (EPS) 0.92
EBITDA 5.43
Effective Tax Rate (%) 41.17
Particulars DEC 2024 (Values in Cr)
Revenue 68.13
Operating Expense 67.68
Net Profit 2.08
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.76
EBITDA 3.00
Effective Tax Rate (%) 2.80
Particulars SEP 2024 (Values in Cr)
Revenue 59.01
Operating Expense 57.02
Net Profit 2.35
Net Profit Margin (%) 3.98
Earnings Per Share (EPS) 0.89
EBITDA 4.21
Effective Tax Rate (%) 20.60
Particulars JUN 2024 (Values in Cr)
Revenue 52.20
Operating Expense 50.35
Net Profit 1.58
Net Profit Margin (%) 3.02
Earnings Per Share (EPS) 0.60
EBITDA 3.42
Effective Tax Rate (%) 31.89
Particulars MAR 2024 (Values in Cr)
Revenue 47.35
Operating Expense 47.88
Net Profit 0.22
Net Profit Margin (%) 0.46
Earnings Per Share (EPS) 0.09
EBITDA 1.08
Effective Tax Rate (%) -43.75
Particulars MAR 2025 (Values in Cr)
Revenue 257.28
Operating Expense 250.06
Net Profit 8.62
Net Profit Margin (%) 3.35
Earnings Per Share (EPS) 3.16
EBITDA 16.07
Effective Tax Rate (%) 27.28
Particulars MAR 2024 (Values in Cr)
Revenue 166.59
Operating Expense 163.73
Net Profit 3.38
Net Profit Margin (%) 2.02
Earnings Per Share (EPS) 1.32
EBITDA 8.28
Effective Tax Rate (%) 31.16
Particulars MAR 2023 (Values in Cr)
Revenue 138.37
Operating Expense 132.84
Net Profit 6.59
Net Profit Margin (%) 4.76
Earnings Per Share (EPS) 2.62
EBITDA 11.10
Effective Tax Rate (%) 23.54
Particulars MAR 2022 (Values in Cr)
Revenue 131.53
Operating Expense 118.97
Net Profit 10.58
Net Profit Margin (%) 8.04
Earnings Per Share (EPS) 4.25
EBITDA 16.99
Effective Tax Rate (%) 25.44
Particulars MAR 2021 (Values in Cr)
Revenue 106.84
Operating Expense 109.44
Net Profit -0.16
Net Profit Margin (%) -0.14
Earnings Per Share (EPS) -0.07
EBITDA 2.96
Effective Tax Rate (%) 46.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 34.81
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.82
EBITDA Margin 4.83
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.94
ROE % -7.42
ROCE % -2.30
Total Debt to Total Equity 0.35
EBITDA Margin 6.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 35.62
ROE % 11.43
ROCE % 14.77
Total Debt to Total Equity 0.10
EBITDA Margin 12.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 26.99
ROE % -1.70
ROCE % -1.88
Total Debt to Total Equity 0.00
EBITDA Margin 1.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 28.02
ROE % 3.98
ROCE % 5.64
Total Debt to Total Equity 0.00
EBITDA Margin 6.34
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.11
ROE % 3.13
ROCE % 4.52
Total Debt to Total Equity 0.07
EBITDA Margin 4.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 37.54
ROE % 7.09
ROCE % 9.24
Total Debt to Total Equity 0.00
EBITDA Margin 8.02
Particulars MAR 2022 (Values in Cr)
Book Value / Share 36.32
ROE % 13.41
ROCE % 17.86
Total Debt to Total Equity 0.00
EBITDA Margin 12.92
Particulars MAR 2021 (Values in Cr)
Book Value / Share 27.02
ROE % -1.63
ROCE % -1.80
Total Debt to Total Equity 0.00
EBITDA Margin 1.81
Particulars MAR 2020 (Values in Cr)
Book Value / Share 28.03
ROE % 4.01
ROCE % 5.67
Total Debt to Total Equity 0.00
EBITDA Margin 6.36
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.00
Total Assets 228.32
Total Liabilities 228.32
Total Equity 89.97
Share Outstanding 25847327
Price to Book Ratio 10.07
Return on Assets (%) -6.28
Return on Capital (%) -13.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.11
Total Assets 158.11
Total Liabilities 158.11
Total Equity 80.35
Share Outstanding 25160327
Price to Book Ratio 7.51
Return on Assets (%) -3.65
Return on Capital (%) -7.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.29
Total Assets 139.09
Total Liabilities 139.09
Total Equity 89.62
Share Outstanding 25160327
Price to Book Ratio 8.19
Return on Assets (%) 6.40
Return on Capital (%) 9.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 85.46
Total Liabilities 85.46
Total Equity 66.29
Share Outstanding 24560327
Price to Book Ratio 5.13
Return on Assets (%) -0.24
Return on Capital (%) -0.32
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 88.47
Total Liabilities 88.47
Total Equity 68.82
Share Outstanding 24560327
Price to Book Ratio 4.65
Return on Assets (%) 3.09
Return on Capital (%) 3.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 173.28
Total Liabilities 173.28
Total Equity 121.77
Share Outstanding 25847327
Price to Book Ratio 10.07
Return on Assets (%) 1.95
Return on Capital (%) 2.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 124.63
Total Liabilities 124.63
Total Equity 94.46
Share Outstanding 25160327
Price to Book Ratio 7.51
Return on Assets (%) 5.29
Return on Capital (%) 6.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.19
Total Assets 125.27
Total Liabilities 125.27
Total Equity 91.37
Share Outstanding 25160327
Price to Book Ratio 8.19
Return on Assets (%) 8.44
Return on Capital (%) 11.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.32
Total Assets 85.51
Total Liabilities 85.51
Total Equity 66.37
Share Outstanding 24560327
Price to Book Ratio 5.13
Return on Assets (%) -0.18
Return on Capital (%) -0.24
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.72
Total Assets 88.49
Total Liabilities 88.49
Total Equity 68.85
Share Outstanding 24560327
Price to Book Ratio 4.65
Return on Assets (%) 3.11
Return on Capital (%) 4.01
Particulars MAR 2024 (Values in Cr)
Net Income -16.16
Cash from Operations -4.45
Cash from Investing -12.90
Cash from Financing 18.77
Net change in Cash -0.11
Free Cash Flow 12.25
Particulars MAR 2023 (Values in Cr)
Net Income -4.69
Cash from Operations 0.13
Cash from Investing 14.70
Cash from Financing -13.88
Net change in Cash -1.18
Free Cash Flow 12.63
Particulars MAR 2022 (Values in Cr)
Net Income 12.43
Cash from Operations 17.06
Cash from Investing -26.65
Cash from Financing 14.27
Net change in Cash 0.95
Free Cash Flow 20.31
Particulars MAR 2021 (Values in Cr)
Net Income -0.36
Cash from Operations -0.82
Cash from Investing 3.82
Cash from Financing -2.41
Net change in Cash 0.51
Free Cash Flow 1.10
Particulars MAR 2020 (Values in Cr)
Net Income 3.86
Cash from Operations 6.64
Cash from Investing -3.52
Cash from Financing -2.87
Net change in Cash -0.85
Free Cash Flow 7.46
Particulars MAR 2024 (Values in Cr)
Net Income 4.90
Cash from Operations -28.62
Cash from Investing -8.66
Cash from Financing 38.07
Net change in Cash -0.73
Free Cash Flow -23.32
Particulars MAR 2023 (Values in Cr)
Net Income 8.62
Cash from Operations -8.15
Cash from Investing 12.75
Cash from Financing -3.78
Net change in Cash -1.32
Free Cash Flow -3.14
Particulars MAR 2022 (Values in Cr)
Net Income 14.19
Cash from Operations 17.39
Cash from Investing -27.05
Cash from Financing 14.27
Net change in Cash 0.87
Free Cash Flow 18.65
Particulars MAR 2021 (Values in Cr)
Net Income -0.31
Cash from Operations -0.77
Cash from Investing 3.90
Cash from Financing -2.46
Net change in Cash 0.59
Free Cash Flow 1.06
Particulars MAR 2020 (Values in Cr)
Net Income 3.88
Cash from Operations 6.64
Cash from Investing -3.54
Cash from Financing -2.97
Net change in Cash -0.96
Free Cash Flow 7.47
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.45 27.82 1.99 279.33 34.11 / 77.70
BLISS GVS PHARMA LTD. 156.00 19.50 1.56 1643.78 103.10 / 184.95
CIPLA LTD. 1513.50 23.76 3.91 122246.58 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 328.70 12.58 2.66 967.40 170.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.45 36.45 5.76 279.33 34.11 / 77.70
AMRUTAJAN HEALTH LTD 712.85 40.55 6.30 2060.89 548.05 / 861.40
ASTRAZENECA PHARMA INDIA LTD. 9090.60 129.83 29.50 22726.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD. 156.00 23.82 1.55 1643.78 103.10 / 184.95

ZOTA HEALTH CARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1199.80 4.60 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 1118.10
  • 26 Days 1004.90
  • 10 Days 1063.80
  • 50 Days 966.40
  • 12 Days 1050.70
  • 100 Days 913.50
  • 20 Days 1019.20
  • 200 Days 829.90
1134.32 PIVOT

First Support

1113.63

First Resistance

1167.63

Second Support

1080.32

Second Resistance

1188.32

Third Support

1059.63

Third Resistance

1221.63

RSI

80.44

ADX

24.73

MACD

45.80

Williams % R

-3.57

Commodity Channel Index (CCI)

228.18

Date

2025-07-04

Week

84766.00

Same Day

107089.00

Month

37028.00

1 Year

1.09

3 Year

0.89

Over 1 Month

24.38%

down

Over 1 Year

98.54%

down

Over 3 Months

47.11%

down

Over 3 Years

64.36%

down

Over 6 Months

40.54%

down

Over 5 Years

52.99%

down

ZOTA HEALTH CARE LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
38.29%
Promoter Holdings
58.1%
FII
3.59%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.26%
Name Shares Category
Himansubhai Muktilal Zota 3135580.0 (10.65%) Shareholding of Promoter and Promoter Group
Ketankumar Chandulal Zota 3051363.0 (10.37%) Shareholding of Promoter and Promoter Group
Manukant Chandulal Zota 2172070.0 (7.38%) Shareholding of Promoter and Promoter Group
Kamlesh Rajanikant Zota 1991103.0 (6.77%) Shareholding of Promoter and Promoter Group
Asha Mukul Agrawal 1630000.0 (5.54%) Public Shareholding
Manishaben Kamleshkumar Zota 1432966.0 (4.87%) Shareholding of Promoter and Promoter Group
Rasilaben Manukantbhai Zota 1000500.0 (3.4%) Shareholding of Promoter and Promoter Group
Zota Ketankumar Chandulal (huf) 981756.0 (3.34%) Shareholding of Promoter and Promoter Group
Varshaben Himanshubhai Zota 899146.0 (3.06%) Shareholding of Promoter and Promoter Group
Anilaben Ketankumar Zota 768250.0 (2.61%) Shareholding of Promoter and Promoter Group
Mukul Mahavir Agrawal 736989.0 (2.5%) Public Shareholding
Valiant Mauritius Partners Offshore Limited 565086.0 (1.92%) Public Shareholding
Jainam Broking Limited 562510.0 (1.91%) Public Shareholding
Viren Manukant Zota 509040.0 (1.73%) Shareholding of Promoter and Promoter Group
Moxesh Ketanbhai Zota 494150.0 (1.68%) Shareholding of Promoter and Promoter Group
3p India Equity Fund 1 415578.0 (1.41%) Public Shareholding
Zota Manukant Chandulal Huf . 206767.0 (0.7%) Shareholding of Promoter and Promoter Group
Dhara Mehta 138147.0 (0.47%) Shareholding of Promoter and Promoter Group
Kenvi Zota 95000.0 (0.32%) Shareholding of Promoter and Promoter Group
Kinjal Nikesh Mehta . 52004.0 (0.18%) Shareholding of Promoter and Promoter Group
Heli Ritesh Shah 32040.0 (0.11%) Shareholding of Promoter and Promoter Group
Krinal V Ankhad 32835.0 (0.11%) Shareholding of Promoter and Promoter Group
Nirmalaben A Shah 11000.0 (0.04%) Shareholding of Promoter and Promoter Group
Manisha Tusharkumar Mehta 11793.0 (0.04%) Shareholding of Promoter and Promoter Group
Praful Ratilal Vora 12630.0 (0.04%) Shareholding of Promoter and Promoter Group
Ashokkumar Chandulal Zota 11762.0 (0.04%) Shareholding of Promoter and Promoter Group
Himanshu Muktilal Zota Huf 8000.0 (0.03%) Shareholding of Promoter and Promoter Group
Niralkumar Muktilal Zota 9632.0 (0.03%) Shareholding of Promoter and Promoter Group
Viren Manukant Zota (huf) 9800.0 (0.03%) Shareholding of Promoter and Promoter Group
Bhikhalal Chhotalal Doshi . 4912.0 (0.02%) Shareholding of Promoter and Promoter Group
Halchandbhai Manilal Mehta 4821.0 (0.02%) Shareholding of Promoter and Promoter Group
Nitaben Rajeshbhai Mehta . 5679.0 (0.02%) Shareholding of Promoter and Promoter Group
Induben Muktilal Zota 2500.0 (0.01%) Shareholding of Promoter and Promoter Group
Sureshkumar Halchandbhai Mehta 2626.0 (0.01%) Shareholding of Promoter and Promoter Group
Vinodchandra Dhirajlal Mehta 4399.0 (0.01%) Shareholding of Promoter and Promoter Group
Kumarpal Rajnikant Mehta 1511.0 (0.01%) Shareholding of Promoter and Promoter Group
Shripal R Mehta 2419.0 (0.01%) Shareholding of Promoter and Promoter Group
Dimple Dhaval Shah 1607.0 (0.01%) Shareholding of Promoter and Promoter Group
Ramila R Mehta 75.0 (0.0%) Shareholding of Promoter and Promoter Group
Arunaben Rameshkumar Shah 700.0 (0.0%) Shareholding of Promoter and Promoter Group
Harshaben Ashvinbhai Siriya 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dixi Kamlesh Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dhruvi Kamlesh Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Zota Dhvani Kamleshbhai 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kriya Kamlesh Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Krisha Kamlesh Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Jiya Himanshu Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Zota Twisha 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pinal Nirbhayakumar Parekh 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Muktilal Chandulal Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Muktilal Chandulal Zota (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajnikant Chandulal Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajnikant Chandulal Zota (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Bhanuben Rajanikant Zota 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kamlesh Rajnikant Zota (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Hetal Hiren Shah 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ratilal Zumchand Vora 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Champaben Halchandbhai Mehta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pushpaben Seventilal Doshi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rasilaben V Siriya 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajnikant Shantilal Mehta 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Manjulaben Pravinbhai Shah 650.0 (0.0%) Shareholding of Promoter and Promoter Group
Anjnaben Shrenikkumar Gandhi 403.0 (0.0%) Shareholding of Promoter and Promoter Group
Chandrikaben Subodhchandra Shah 302.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashokkumar Chandulal Zota (huf) 1400.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ZOTA HEALTH CARE LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2023 1.0 Final 23 Sep 2023 Equity shares
19 Sep 2022 1.5 Final 21 Sep 2022 Equity shares
22 Sep 2021 1.0 Final 24 Sep 2021 Equity shares
17 Sep 2020 1.0 Final 19 Sep 2020 Equity shares
12 Sep 2019 1.0 Final 14 Sep 2019 Equity shares
02 Aug 2018 3.0 Final 04 Aug 2018 Equity shares
Ex-Date Ex-Bonus Ratio
26 Jul 2019 25 Jul 2019 4:10
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ZOTA HEALTH CARE LIMITED Share Price

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost.

The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain. Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business. The Company's state-of-the-art manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts, i.e. 30% to 90%, to their branded equivalents. Davaindia focuses on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments.

The Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company's distribution network across India. In domestic Marketing business, the Company procures finished dosage forms (FDFs) from domestic formulation manufactures and then market them under its portfolio of brands. It has a set of manufacturing partners recognized by the WHO with a rigorous focus on product quality. With a portfolio of more than 3000 products in various categories, such as generics, OTC products, allopathic, ayurvedic, etcetera, the Company cater to a variety of ailments. Currently, the Company has over 1050 distributors spread around the country. Instead of the Company directly engaging in sales, distribution, and promotion activities, its distributors engage in ethical marketing or other sales, distribution, and promotion activities on their own. Instead, it provide distributors directly with incentives to help them sell products more effectively.

Secondly, the exports business vertical started in 2010, following the establishment of formulations manufacturing facility in the Sachin SEZ. The Company is required to export products from this unit in accordance with the laws governing this SEZ. At present, it has product approvals in 30 countries, particularly in the semi-regulated and regulated markets in the African, Asian, CIS, and Latin American countries. In this facility, the Company make around 250 formulations for direct exports and contract manufacturing. . At present, the Company has 253 dossiers approved across multiple countries, and another 311 dossiers have been filed and are pending approval. It significantly increased efforts and investments towards product registration, the results of which are now apparent in the form of product approvals and expansion of export operations.

In the Retail Pharmacy Chain business vertical, the Company operates a chain of pharmacy stores under the brand - 'Davaindia'. Davaindia focuses only on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments. This concept started with three pilot stores in 2017 and has been scaled up to become the largest private-sector generic pharmacy chain with more than 591 stores as of March 2021. Davaindia operates on a unique asset-light franchise model for majority stores. These stores are engaged in exclusive sales of Davaindia products, with more than 95% of products being private-label.

In all areas and media, such as TV commercials, printing, digital & social media, radio, among others, the Company has undertaken bold and aggressive marketing and promotion activities with the firm intention of creating top-of-the-mind brand recall for Davaindia. Davaindia - being a front-runner in private sector generic pharmacy assumed the responsibility to create awareness, propagate virtues and debunk misconceptions about generic drugs.

In 2019, the Company opened ~150 Davaindia outlets. Davaindia expanded to over 250 outlets, becoming the fastest-growing private
sector generic pharmacy chain in India in 2020.

Parent organization Indian Private
NSE symbol ZOTA
Founded 2000
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Zota Health Care Ltd?

Answer Field

Zota Health Care Ltd share price is for NSE ₹ 1,199.80 & for BSE ₹ 0.00 as on Jul 04 2025 03:30 PM.

What is the Market Cap of Zota Health Care Ltd Share?

Answer Field

The market cap of Zota Health Care Ltd for NSE ₹ 3,101.16 & for BSE ₹ 0.00 as on Jul 04 2025 03:30 PM.

What is the 52 Week High and Low of Zota Health Care Ltd?

Answer Field

The 52 Week High and Low of Zota Health Care Ltd for NSE is ₹ 1,210.25 and ₹ 535.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Zota Health Care Ltd?

Answer Field

The 1 year returns on the stock has been 98.54%.

What is the P/E Ratio of Zota Health Care Ltd Share?

Answer Field

As on Jul 04 2025 03:30 PM the price-to-earnings (PE) ratio for Zota Health Care Ltd share is 409.49.

What is the PB ratio of Zota Health Care Ltd Share?

Answer Field

As on Jul 04 2025 03:30 PM, the price-to-book (PB) ratio for Zota Health Care Ltd share is 132.14.

How to Buy Zota Health Care Ltd Share?

Answer Field

You can trade in Zota Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Zota Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Zota Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Zota Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|